TEHRAN -- Secretary of Iran’s Supreme National Security Council (SNSC) Ali Shamkhani said Saturday the occupying regime of Israel remains the “biggest enemy” of the Muslim and Arab world, reiterating that Tehran seeks cooperation with neighbors to secure regional interests against Tel Aviv.
:Don’t forget: The Zionist regime is the Islamic world’s enemy,” he tweeted.
Shamkhani also referred to direct talks between Saudi Arabia and Iran, saying Tehran’s “active participation” in the Iraq-hosted negotiations “stems from the Islamic Republic’s principled strategy of cooperation with its neighbors based on securing bilateral and regional interests.”
The remarks came after Saudi Crown Prince Muhammad bin Salman described the occupying regime of Israel as a “potential ally” with shared interests, not an enemy.
“We don’t look at Israel as an enemy,” he said during an interview with The Atlantic, the full text of which was published by the Saudi state news agency SPA on Thursday.
“We look to them as a potential ally, with many interests that we can pursue together. But we have to solve some issues before we get to that.”
Asked about Riyadh’s ties with Tehran, the Saudi heir to the throne said the kingdom intends to continue “detailed talks” with Iran to reach a satisfactory agreement for both.
The talks, he added, would enable reaching “a good situation and mark a bright future” for both sides.
“Iran is a neighbor forever. We cannot get rid of them and they cannot get rid of us,” bin Salman noted.
Saudi Arabia severed diplomatic relations with Iran in January 2016 after Iranian protesters, enraged by the Saudi execution of prominent Shia cleric Sheikh Nimr Baqir al-Nimr, stormed its embassy in Tehran.
For years, the kingdom pursued a confrontational foreign policy toward the Islamic Republic, but it appears that it has recently changed tack.
The two Middle East heavyweights have held four rounds of talks in Iraq since last April, including a meeting in December under the administration of President Ebrahim Raisi, who assumed office in mid-2021.